New Study Published About PAH in Connective-Tissue Disease
Major Paper on Recommendations for Screening and Detection of Connective-Tissue Disease Associated with Pulmonary Arterial Hypertension is Published Today
The medical journal, Arthritis & Rheumatism, this week published a major paper on recommendations to the medical community on guideline for screening and detection of PAH in connective tissue disease, particularly in systemic sclerosis. This paper was the collaborative work of an international group of medical experts and was made possible through a joint project of the Scleroderma Foundation and the Pulmonary Hypertension Association through unrestricted medical education grants from Actelion Pharmaceuticals, US, Inc., Gilead Sciences, and United Therapeutics Corporation.
- Patients & Newly Diagnosed
- Healthcare Professionals